Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)

ClinicalTrials.gov ID: NCT00107666

Public ClinicalTrials.gov record NCT00107666. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Proof of Concept Clinical Study of CTI-01 in Patients Undergoing Major Cardiac Surgery With Cardiopulmonary Bypass

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Over 500,000 patients undergo cardiac surgery with CPB in the United States annually. Although mortality rates have decreased with advances in perioperative care, many patients are affected by postoperative organ dysfunction. The incidence of complications may exceed 30%. It has been speculated that an exaggerated inflammatory response to surgical trauma and the CPB machine are likely causes for this morbidity. Factors predisposing organ dysfunction include tissue injury, endotoxemia, and oxidative stress. High risk patients can be identified preoperatively through the validated Parsonnet Additive Risk Score. CTI-01 has demonstrated potent anti-inflammatory and tissue protection activity in multiple animal models of disease including pancreatitis, ischemia-reperfusion injury, sepsis, renal injury, and endotoxemia. These findings support its clinical use in critical care medicine including cardiac surgery. Patients will receive a total of six doses, administered intravenously just prior to and after surgery.

Study identification

NCT ID
NCT00107666
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Critical Therapeutics
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2005 (Type not available)
Primary completion
Not listed
Completion
Apr 2006 (Type not available)
Last update posted
Mar 17, 2006

2005 – 2006

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Saddleback Memorial Medical Center Laguna Hills California 92653 —
University of Southern California Los Angeles California 90033 —
Kaiser Permanente San Francisco California 94115 —
Washington Hospital Center Washington D.C. District of Columbia 20010 —
University of Florida Gainesville Florida 32610 —
Research Support Personnel Wichita Kansas 67208 —
Peninsula Regional Medical Center Salisbury Maryland 21801 —
Baystate Medical Center Springfield Massachusetts 01199 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
NYU Medical Center New York New York 10016 —
Duke University Medical Center Durham North Carolina 27710 —
East Carolina University - Brody School of Medicine Greenville North Carolina 27834 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Chester County Hospital - The Cardiovasular Center West Chester Pennsylvania 19380 —
St. Luke's Episcopal Hospital/Texas Heart Institute Houston Texas 77030 —
MultiCare Health System Tacoma Washington 98405 —
Medical College of Wisconsin - VA Medical Center Milwaukee Wisconsin 53295 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00107666, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2006 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00107666 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →